Horrell Capital Management’s St Jude Medical STJ Stock Holding History

Horrell Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-225	Closed	-$15K	–	307
2015 Q1	$15K	Hold	225	–	–	0.01%	235
2014 Q4	$15K	Hold	225	–	–	0.01%	234
2014 Q3	$14K	Hold	225	–	–	0.01%	235
2014 Q2	$16K	Hold	225	–	–	0.01%	233
2014 Q1	$15K	Hold	225	–	–	0.01%	219
2013 Q4	$14K	Hold	225	–	–	0.01%	219
2013 Q3	$12K	Hold	225	–	–	0.01%	218
2013 Q2	$10K	Buy	+225	New	+$9.75K	0.01%	235

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Horrell Capital Management's STJ Position: Q2 2015 in Review

Horrell Capital Management sold out of St Jude Medical (STJ) in Q2 2015, closing a stake of 225 shares — an estimated $15K sold.

Horrell Capital Management first reported a position in STJ in Q2 2013 and held it in 8 quarters. The position peaked at $16K in Q2 2014. 608 funds tracked by Wall St. Rank hold STJ as of Q2 2015.

Horrell Capital Management reported no remaining St Jude Medical position as of Q2 2015 after selling out during the quarter.
Horrell Capital Management sold 225 St Jude Medical shares in Q2 2015, an estimated $15K.
Horrell Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 8 quarters.
Horrell Capital Management's St Jude Medical position peaked at $16K in Q2 2014.
608 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2015.

Based on Horrell Capital Management's 13F filing for Q2 2015, filed 21 Jul 2015.